Frontida BioPharm, Inc., a Minority-Owned CDMO Announced Today the Appointment of Steven Roese as Vice President of Quality
Frontida BioPharm, Inc., a minority-owned pharmaceutical Contract Development and Manufacturing Organization based in Philadelphia and Chicago areas, announced today the appointment of Steven Roese as Vice President of Quality. Mr. Roese joins Frontida with over 25 years of experience in quality operations and pharmaceutical industry management.
View full press release